|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Taiwan University Hospital |
|---|---|
| Information provided by: | National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT00172354 |
Purpose
Out-of-hospital cardiac arrest (OHCA) is an important issue for the emergency physicians and co-workers. How to improve the return of spontaneous circulation (ROSC) rate and prognosis of these patients challenges the emergency team. When encounters stress, the hypothalamus of human releases corticotropin releasing hormone, which in turn stimulates the pituitary gland to release ACTH. Then ACTH acts on the adrenal gland to release glucocorticoid to against stress. Foley PJ et al found the dogs with bilateral adrenalectomy had lower ROSC rate during resuscitation than those without surgery[1]. Karl H. Linder et al showed OHCA patients had high serum vasopressin and ACTH level but low serum cortisol level. Besides, the serum cortisol level had a negative correlation with collapse duration (no CPR duration)[2]. Studies also revealed the successfully resuscitated patients had higher serum ACTH and cortisol level than non-resuscitated ones[2,3]. In addition, the serum cortisol level was found to be correlated with short term survival rate and hemodynamic status in resuscitated OHCA patients[3]. Animal study also showed mice receiving higher dosage of hydrocortisone had higher ROSC rate and lower epinephrine requirement than those receiving lower dosage of hydrocortisone or normal saline.
<Reference>
| Condition | Intervention |
|---|---|
|
Heart Arrest |
Drug: Hydrocortisone |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Hydrocortisone in Patients of Out-of-Hospital Cardiac Arrest |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Wen-Jone Chen, PhD | 886-2-23562831 | jone@ha.mc.ntu.edu.tw |
| Contact: Min-Shan Tsai, MD | 886-2-23562831 | mshan@ha.mc.ntu.edu.tw |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 100 | |
| Contact: Wen-Jone Chen, PhD 886-2-23562831 jone@ha.mc.ntu.edu.tw | |
| Study Director: | Wen-Jone Chen, PhD | Chiarman of NTUH emergency department |
More Information
| ClinicalTrials.gov Identifier: | NCT00172354 History of Changes |
| Other Study ID Numbers: | 930502 |
| Study First Received: | September 12, 2005 |
| Last Updated: | November 23, 2005 |
| Health Authority: | Taiwan: Department of Health |
|
Heart Arrest Out-of-Hospital Cardiac Arrest Heart Diseases Cardiovascular Diseases Cortisol succinate |
Hydrocortisone acetate Hydrocortisone Anti-Inflammatory Agents Therapeutic Uses Pharmacologic Actions |